A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID

[1]  C. Cancrini,et al.  Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency. , 2024, Nature medicine.

[2]  G. Cuvelier,et al.  Updated management guidelines for adenosine deaminase deficiency. , 2023, The journal of allergy and clinical immunology. In practice.

[3]  M. Bernardo,et al.  ISAnalytics enables longitudinal and high-throughput clonal tracking studies in hematopoietic stem cell gene therapy applications , 2022, Briefings Bioinform..

[4]  S. Ogawa,et al.  CARD11 mutation and HBZ expression induce lymphoproliferative disease and adult T-cell leukemia/lymphoma , 2022, Communications Biology.

[5]  I. Lossos,et al.  LMO2 expression is frequent in T-lymphoblastic leukemia and correlates with survival, regardless of T-cell stage , 2022, Modern Pathology.

[6]  S. Galimberti,et al.  A systematic review and meta-analysis of gene therapy with hematopoietic stem and progenitor cells for monogenic disorders , 2022, Nature Communications.

[7]  A. Fischer,et al.  Hematopoietic cell transplantation in severe combined immunodeficiency: the SCETIDE 2006-2014 European cohort. , 2021, The Journal of allergy and clinical immunology.

[8]  F. Bushman,et al.  Retrieval of vector integration sites from cell-free DNA , 2021, Nature Medicine.

[9]  Aaron M. Rosenfeld,et al.  Long-term Outcomes after Gene Therapy for Adenosine Deaminase Severe Combined Immune Deficiency (ADA SCID). , 2021, Blood.

[10]  J. Klco,et al.  Advances in germline predisposition to acute leukaemias and myeloid neoplasms , 2020, Nature Reviews Cancer.

[11]  A. Thrasher,et al.  Gene therapy using haematopoietic stem and progenitor cells , 2020, Nature Reviews Genetics.

[12]  Xiaoming Liu,et al.  dbNSFP v4: a comprehensive database of transcript-specific functional predictions and annotations for human nonsynonymous and splice-site SNVs , 2020, Genome Medicine.

[13]  B. Raught,et al.  ARID1a Associates with Lymphoid-Restricted Transcription Factors and Has an Essential Role in T Cell Development , 2020, The Journal of Immunology.

[14]  Claude C. Warzecha,et al.  Ldb1 is required for Lmo2 oncogene-induced thymocyte self-renewal and T-cell Acute Lymphoblastic Leukemia. , 2020, Blood.

[15]  C. von Kalle,et al.  Comprehensive genomic characterization of gene therapy-induced T-cell acute lymphoblastic leukemia , 2020, Leukemia.

[16]  F. Bushman.  Retroviral Insertional Mutagenesis in Humans: Evidence for Four Genetic Mechanisms Promoting Expansion of Cell Clones. , 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

[17]  M. Hershfield,et al.  Morbidity in an adenosine deaminase-deficient patient during 27 years of enzyme replacement therapy. , 2019, Clinical immunology.

[18]  Dennis Kostka,et al.  scds: computational annotation of doublets in single-cell RNA sequencing data , 2019, Bioinform..

[19]  Kamil Slowikowski,et al.  Fast, sensitive, and accurate integration of single cell data with Harmony , 2019, Nature Methods.

[20]  E. Bertini,et al.  Aberrant Function of the C-Terminal Tail of HIST1H1E Accelerates Cellular Senescence and Causes Premature Aging. , 2019, American journal of human genetics.

[21]  M. Raffeld,et al.  Clonal expansion of CAR T cells harboring lentivector integration in the CBL gene following anti-CD22 CAR T-cell therapy. , 2019, Blood advances.

[22]  M. Malumbres,et al.  Detection of novel fusion-transcripts by RNA-Seq in T-cell lymphoblastic lymphoma , 2019, Scientific Reports.

[23]  G. Tonon,et al.  Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation , 2019, Nature Medicine.

[24]  G. Roboz,et al.  Clonal Hematopoiesis and therapy related MDS/AML. , 2019, Best practice & research. Clinical haematology.

[25]  S. Perrotta,et al.  Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia , 2019, Nature Medicine.

[26]  Paul J. Hoffman,et al.  Comprehensive Integration of Single-Cell Data , 2018, Cell.

[27]  S. Pro,et al.  Mutations in KCNK4 that Affect Gating Cause a Recognizable Neurodevelopmental Syndrome. , 2018, American journal of human genetics.

[28]  Y. Hannun,et al.  Evaluating intrinsic and non-intrinsic cancer risk factors , 2018, Nature Communications.

[29]  C. Doglioni,et al.  First Occurrence of Plasmablastic Lymphoma in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Disease Patient and Review of the Literature , 2018, Front. Immunol..

[30]  Ivan Merelli,et al.  VISPA2: a scalable pipeline for high-throughput identification and annotation of vector integration sites , 2017, BMC Bioinformatics.

[31]  A. Aiuti,et al.  Twenty-Five Years of Gene Therapy for ADA-SCID: From Bubble Babies to an Approved Drug. , 2017, Human gene therapy.

[32]  Luigi Naldini,et al.  Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1 , 2017, Science Translational Medicine.

[33]  F. Moretti,et al.  Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID): Molecular Pathogenesis and Clinical Manifestations , 2017, Journal of Clinical Immunology.

[34]  Cheng Cheng,et al.  THE GENOMIC LANDSCAPE OF PEDIATRIC AND YOUNG ADULT T-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA , 2017, Nature Genetics.

[35]  L. Biasco,et al.  Multiparametric Whole Blood Dissection: A one‐shot comprehensive picture of the human hematopoietic system , 2017, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[36]  Aaron R Cooper,et al.  Cytoreductive conditioning intensity predicts clonal diversity in ADA-SCID retroviral gene therapy patients. , 2017, Blood.

[37]  R. Crystal,et al.  Analysis of the AAVrh. 10 Capsid Structure and Its Antigenic and Receptor Interactions , 2017 .

[38]  Kin Chung Lam,et al.  High-resolution TADs reveal DNA sequences underlying genome organization in flies , 2017, Nature Communications.

[39]  J. Cools,et al.  The genetics and molecular biology of T-ALL. , 2017, Blood.

[40]  Quan Li,et al.  InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines. , 2017, American journal of human genetics.

[41]  V. Beneš,et al.  Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemia , 2017, Blood Cancer Journal.

[42]  Gill Bejerano,et al.  M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity , 2016, Nature Genetics.

[43]  J. Puck,et al.  Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency. , 2016, Blood.

[44]  Neva C. Durand,et al.  Juicer Provides a One-Click System for Analyzing Loop-Resolution Hi-C Experiments. , 2016, Cell systems.

[45]  A. Spencer,et al.  Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies , 2016, Cancer biology & medicine.

[46]  Xiaoyu Chen,et al.  Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications , 2016, Bioinform..

[47]  Steve Lee,et al.  Canvas: versatile and scalable detection of copy number variants , 2016, bioRxiv.

[48]  J. Tchinda,et al.  Successful Combination of Sequential Gene Therapy and Rescue Allo-HSCT in Two Children with X-CGD - Importance of Timing. , 2015, Current gene therapy.

[49]  Raphael Gottardo,et al.  Orchestrating high-throughput genomic analysis with Bioconductor , 2015, Nature Methods.

[50]  F. Granucci,et al.  Wiskott–Aldrich syndrome protein deficiency in natural killer and dendritic cells affects antitumor immunity , 2014, European journal of immunology.

[51]  Michael Rothe,et al.  Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity , 2014, Science Translational Medicine.

[52]  J. Shendure,et al.  A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.

[53]  Mauricio O. Carneiro,et al.  From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline , 2013, Current protocols in bioinformatics.

[54]  C. von Kalle,et al.  Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy , 2013, Science.

[55]  Luca Biasco,et al.  Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome , 2013, Science.

[56]  Semyon Kruglyak,et al.  Isaac: ultra-fast whole-genome secondary analysis on Illumina sequencing platforms , 2013, Bioinform..

[57]  Daniel Ruiz,et al.  A Fast Algorithm for Matrix Balancing , 2013, Web Information Retrieval and Linear Algebra Algorithms.

[58]  X. Chen,et al.  Lmo2 Induces Hematopoietic Stem Cell‐Like Features in T‐Cell Progenitor Cells Prior to Leukemia , 2013, Stem cells.

[59]  Pablo Cingolani,et al.  © 2012 Landes Bioscience. Do not distribute. , 2022 .

[60]  Anat Melamed,et al.  Estimating abundances of retroviral insertion sites from DNA fragment length data , 2012, Bioinform..

[61]  J. Wingard,et al.  Malignancies after hematopoietic cell transplantation for primary immune deficiencies: a report from the Center for International Blood and Marrow Transplant Research. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[62]  C. von Kalle,et al.  Insertion sites in engrafted cells cluster within a limited repertoire of genomic areas after gammaretroviral vector gene therapy. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[63]  C. von Kalle,et al.  Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection. , 2011, Blood.

[64]  Felix Krueger,et al.  Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications , 2011, Bioinform..

[65]  Luca Biasco,et al.  Integration profile of retroviral vector in gene therapy treated patients is cell-specific according to gene expression and chromatin conformation of target cell , 2011, EMBO molecular medicine.

[66]  Frederic D. Bushman,et al.  Dynamics of gene-modified progenitor cells analyzed by tracking retroviral integration sites in a human SCID-X1 gene therapy trial. , 2010, Blood.

[67]  M. Cavazzana‐Calvo,et al.  Lymphomagenesis in SCID-X1 Mice Following Lentivirus-mediated Phenotype Correction Independent of Insertional Mutagenesis and γc Overexpression. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[68]  S. Burns,et al.  WASP: a key immunological multitasker , 2010, Nature Reviews Immunology.

[69]  C. D. de Graaf,et al.  The Lmo2 Oncogene Initiates Leukemia in Mice by Inducing Thymocyte Self-Renewal , 2010, Science.

[70]  Hans Martin,et al.  Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease , 2010, Nature Medicine.

[71]  Richard Durbin,et al.  Fast and accurate long-read alignment with Burrows–Wheeler transform , 2010, Bioinform..

[72]  Alessandro Aiuti,et al.  Hot spots of retroviral integration in human CD34+ hematopoietic cells. , 2007, Blood.

[73]  T. Lu,et al.  Unique risk factors for insertional mutagenesis in a mouse model of XSCID gene therapy. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[74]  Yang Du,et al.  Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1 , 2006, Nature Medicine.

[75]  Cameron S. Osborne,et al.  LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1 , 2003, Science.

[76]  Long-Cheng Li,et al.  MethPrimer: designing primers for methylation PCRs , 2002, Bioinform..

[77]  M. Evans,et al.  The Oncogenic Cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development , 1994, Cell.

[78]  I. Amit,et al.  Comprehensive mapping of long range interactions reveals folding principles of the human genome , 2011 .